These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
289 related items for PubMed ID: 23302970
1. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. Carroll RC, Craft RM, Snider CC, Aligeti VR, Wortham DC. Anesth Analg; 2013 Feb; 116(2):282-6. PubMed ID: 23302970 [Abstract] [Full Text] [Related]
5. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study. Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US. Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955 [Abstract] [Full Text] [Related]
6. Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. Gremmel T, Steiner S, Seidinger D, Koppensteiner R, Panzer S, Kopp CW. Platelets; 2011 Jun 26; 22(3):188-95. PubMed ID: 21231857 [Abstract] [Full Text] [Related]
7. Aspirin response evaluated by the VerifyNow Aspirin System and light transmission aggregometry. Nielsen HL, Kristensen SD, Thygesen SS, Mortensen J, Pedersen SB, Grove EL, Hvas AM. Thromb Res; 2008 Jun 26; 123(2):267-73. PubMed ID: 18499236 [Abstract] [Full Text] [Related]
8. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study. DiChiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, Suarez TA, Bailon O, Singla A, Gurbel PA. Diabetes; 2007 Dec 26; 56(12):3014-9. PubMed ID: 17848625 [Abstract] [Full Text] [Related]
12. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients. Zisman E, Erport A, Kohanovsky E, Ballagulah M, Cassel A, Quitt M, Pizov R. Eur J Anaesthesiol; 2010 Jul 26; 27(7):617-23. PubMed ID: 20035230 [Abstract] [Full Text] [Related]
13. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population. Faraday N, Becker DM, Yanek LR, Herrera-Galeano JE, Segal JB, Moy TF, Bray PF, Becker LC. Am J Cardiol; 2006 Sep 15; 98(6):774-9. PubMed ID: 16950183 [Abstract] [Full Text] [Related]
14. Screening for aspirin resistance in stable coronary artery patients by three different tests. Chakroun T, Addad F, Abderazek F, Ben-Farhat M, Hamdi S, Gamra H, Hassine M, Ben-Hamda K, Samama MM, Elalamy I. Thromb Res; 2007 Sep 15; 121(3):413-8. PubMed ID: 17553552 [Abstract] [Full Text] [Related]
15. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin? Markuszewski L, Rosiak M, Golanski J, Rysz J, Spychalska M, Watala C. Basic Clin Pharmacol Toxicol; 2006 May 15; 98(5):503-9. PubMed ID: 16635110 [Abstract] [Full Text] [Related]
18. Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study. Velik-Salchner C, Maier S, Innerhofer P, Streif W, Klingler A, Kolbitsch C, Fries D. Anesth Analg; 2008 Dec 15; 107(6):1798-806. PubMed ID: 19020120 [Abstract] [Full Text] [Related]
19. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment. Temperilli F, Rina A, Massimi I, Montemari AL, Guarino ML, Zicari A, Pulcinelli FM. Platelets; 2015 Dec 15; 26(8):783-7. PubMed ID: 25734355 [Abstract] [Full Text] [Related]
20. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke. Dharmasaroja PA, Sae-Lim S. J Stroke Cerebrovasc Dis; 2014 Dec 15; 23(5):953-7. PubMed ID: 24126290 [Abstract] [Full Text] [Related] Page: [Next] [New Search]